Biotech

All Articles

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Funds Lifestyle Sciences, Arc Endeavor Partners ...

Orion to use Aitia's 'digital twins' to discover brand new cancer medications

.Finnish biotech Orion has spied prospective in Aitia's "digital twin" technology to build brand new...

Windtree's shock med brings up high blood pressure in most current stage 2 succeed

.While Windtree Therapies has actually had a hard time to grow the financial origins needed to have ...

2 cancer biotechs merge, creating worldwide footprint

.OncoC4 is actually taking AcroImmune-- and also its own in-house scientific manufacturing capabilit...

Amgen records initial phase 3 gain for $400M dermatitis drug

.Amgen has actually shared (PDF) the first phase 3 data on its own $400 million chronic eczema medic...

Biogen, UCB file phase 3 lupus gain after neglecting earlier test

.Biogen and UCB's depend advancing into stage 3 on the back of a broken study wants to have actually...

Aptadir really hopes new RNA preventions may reverse difficult cancers cells

.Italian biotech Aptadir Therapeutics has actually introduced with the commitment that its own pipel...

Wave surfs DMD excellence to regulators' doors, sending stockpile

.Wave Life Sciences has met its target in a Duchenne muscular dystrophy (DMD) research, positioning ...

Sanofi plucks brand new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma crease...

Achilles droplets tissue treatment course, supports for layoffs after missing 'business practicality' objectives

.Achilles Therapeutics has shreded its own tactic. The British biotech is actually quiting working o...